Ubs Asset Management Americas Inc Olema Pharmaceuticals, Inc. Transaction History
Ubs Asset Management Americas Inc
- $277 Billion
- Q1 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 28,790 shares of OLMA stock, worth $307,189. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,790
Previous 21,378
34.67%
Holding current value
$307,189
Previous $299,000
8.7%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding OLMA
# of Institutions
129Shares Held
56MCall Options Held
55KPut Options Held
41.3K-
Bvf Inc San Francisco, CA9.14MShares$97.5 Million3.1% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY7.9MShares$84.3 Million3.36% of portfolio
-
Logos Global Management LP San Francisco, CA4.38MShares$46.8 Million4.62% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.23MShares$34.4 Million1.21% of portfolio
-
Black Rock Inc. New York, NY3.22MShares$34.3 Million0.0% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $431M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...